ghk-cu systemic injection safety Mitigating Pain: Tips and Tricks | Gabriel Alizaidy, MD, MS posted on the topic GHK-CU - Beverly Hills Rejuvenation

They produce no visual signal, no odor, no change in solution clarity

In the Phase 2 obesity trial it produced about 24% weight loss at 12 mg over 48 weeks, the most of any drug in the class, and it cut liver fat by 86% in the people who started with fatty liver. In the 80-week Phase 3 obesity trial of 2,300 adults with an average BMI of 40, 12 mg produced 28% weight loss and 9 mg reached 26%

2007 Jul;164(7):1115-7

Understanding specific risk factors helps determine which peptide approaches might be most relevant for different populations

Additionally, Blue Sky MD patients can earn free B12 injections by signing up for our free rewards app